Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-04-11 2:02 pm Purchase | 13G | HERON THERAPEUTICS INC HRTX | STATE STREET CORP STT | 12,923,369 12.65% | 5,230,958 (+68.00%) | View |
| 2022-02-14 4:15 pm Purchase | 13G | HERON THERAPEUTICS INC HRTX | BAKER BROS. ADVISORS LP | 8,131,678 8% | 66,846 (+0.83%) | View |
| 2022-02-14 4:00 pm Purchase | 13G | HERON THERAPEUTICS INC HRTX | TANG CAPITAL PARTNERS LP | 7,783,688 7.6% | 144,588 (+1.89%) | View |
| 2022-02-14 2:15 pm Purchase | 13G | HERON THERAPEUTICS INC HRTX | ArrowMark Colorado Holdings LLC | 6,405,865 6.28% | 1,044,254 (+19.48%) | View |
| 2022-02-14 11:17 am Purchase | 13G | HERON THERAPEUTICS INC HRTX | UBS OCONNOR LLC | 8,275,000 8.12% | 8,275,000 (New Position) | View |
| 2022-02-11 09:52 am Purchase | 13G | HERON THERAPEUTICS INC HRTX | STATE STREET CORP STT | 7,692,411 7.55% | 7,692,411 (New Position) | View |
| 2022-02-10 08:17 am Purchase | 13G | HERON THERAPEUTICS INC HRTX | VANGUARD GROUP INC | 9,609,045 9.43% | 1,297,277 (+15.61%) | View |
| 2022-02-04 09:27 am Sale | 13G | HERON THERAPEUTICS INC HRTX | WELLINGTON MANAGEMENT GROUP LLP | 1,638,273 1.61% | -5,297,641 (-76.38%) | View |
| 2022-02-03 3:01 pm Sale | 13G | HERON THERAPEUTICS INC HRTX | FRANKLIN RESOURCES INC BEN | 11,967,465 11.7% | -721,237 (-5.68%) | View |
| 2022-02-01 5:08 pm Purchase | 13G | HERON THERAPEUTICS INC HRTX | BlackRock Inc. BLK | 7,682,201 7.5% | 795,269 (+11.55%) | View |
| 2022-01-24 12:02 pm Purchase | 13G | HERON THERAPEUTICS INC HRTX | JPMORGAN CHASE & CO JPM | 6,254,209 6.1% | 6,254,209 (New Position) | View |
| 2021-02-16 5:09 pm Purchase | 13G | HERON THERAPEUTICS INC HRTX | BAKER BROS. ADVISORS LP | 8,064,832 8.7% | 84,979 (+1.06%) | View |
| 2021-02-16 4:15 pm Sale | 13G | HERON THERAPEUTICS INC HRTX | TANG CAPITAL PARTNERS LP | 7,639,100 7.8% | -2,110,244 (-21.64%) | View |
| 2021-02-16 1:29 pm Purchase | 13G | HERON THERAPEUTICS INC HRTX | ArrowMark Colorado Holdings LLC | 5,361,611 5.9% | 5,361,611 (New Position) | View |
| 2021-02-11 1:43 pm Sale | 13G | HERON THERAPEUTICS INC HRTX | JANUS HENDERSON GROUP PLC JHG | 0 0% | -4,915,313 (Position Closed) | View |
| 2021-02-10 10:57 am Purchase | 13G | HERON THERAPEUTICS INC HRTX | VANGUARD GROUP INC | 8,311,768 9.15% | 455,202 (+5.79%) | View |
| 2021-02-04 11:27 am Purchase | 13G | HERON THERAPEUTICS INC HRTX | WELLINGTON MANAGEMENT GROUP LLP | 6,935,914 7.63% | 2,344,285 (+51.06%) | View |
| 2021-02-01 2:39 pm Purchase | 13G | HERON THERAPEUTICS INC HRTX | FRANKLIN RESOURCES INC BEN | 12,688,702 14% | 327,291 (+2.65%) | View |
| 2021-01-29 09:56 am Purchase | 13G | HERON THERAPEUTICS INC HRTX | BlackRock Inc. BLK | 6,886,932 7.6% | 1,118,730 (+19.39%) | View |
| 2020-11-19 4:00 pm Purchase | 13G | HERON THERAPEUTICS INC HRTX | TANG CAPITAL PARTNERS LP | 9,749,344 9.99% | 169,415 (+1.77%) | View |